Please join the TIPG as we gain valuable insight into recent case law with two leading pharmaceutical patent litigators, Sheldon Hamilton (Smart & Biggar) and Richard Naiberg (Goodmans LLP). Updates on the non-infringing alternative defence, promise and utility/sound prediction and expert blinding will be discussed.
Sheldon Hamilton has been recognized as one of Canada’s leading patent litigation lawyers. For close to 20 years, Sheldon has acted as counsel for many of the world’s most innovative companies in relation to commercially significant products. Sheldon has particular experience in pharmaceutical litigation, appearing as both trial and appellate counsel, including in proceedings under the Patented Medicines (Notice of Compliance) Regulations. Sheldon has extensive trial experience focusing on issues of patent infringement and validity, and damage quantification.
Sheldon has been recognized by a range of leading Canadian and international publications, including IAM Patent Litigation 250 — The World’s Leading Patent Litigators, IAM Life Sciences 250 – The World’s Leading Life Sciences Patent Litigators, Benchmark Canada, Chambers Global, and The Best Lawyers in Canada.
Richard Naiberg is a partner in the Intellectual Property Group and Litigation Group at Goodmans LLP.
Richard’s practice is principally focussed on intellectual property litigation and he has been counsel on a large number of cases involving patents, trade-marks and copyrights. He has very extensive experience in disputes determined under the Patented Medicines (Notice of Compliance) Regulations. Richard also provides strategic advice on the development, acquisition, sale and protection of technology and intellectual property assets.
Richard is recognized by The Canadian Legal Lexpert Directory for IP litigation, PLC Which Lawyer? for IP and life sciences, The Best Lawyers in Canada for IP and Euromoney’s Guide to the World’s Leading Patent Law Practitioners. He is a frequent speaker at industry conferences and the author of various articles on intellectual property law and advocacy. Richard also lectures at the Rotman School of Business and at Osgoode Hall Law School on issues of intellectual property and health law.
